Cosmo Pharmaceuticals investor relations material

Established in 1997, Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gastroenterology and endoscopy worldwide. The company offers drug delivery systems primarily rectal, topical, oral, nasal wafer based systems. Cosmo Pharmaceuticals aims to become a global leader in optimized therapies for selected gastroenterology and colorectal disease areas by leveraging its proprietary and differentiated technology.